Drug
Gsk1265744
Gsk1265744: highest development phase Phase 1, developed by Shionogi. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Shionogi
Trials
| Drug | Phase | Indication |
|---|---|---|
| GSK1265744 10 mg oral solution NCT00812318 | Phase 1 | HIV Infection |
Latest
No recent events.
Follow Gsk1265744 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.